View Older Stories View More Recent Stories

Aug 26, 2020 07:00AM Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection
Aug 24, 2020 08:00AM Connect Biopharma Completes $115 Million Series C Financing to Advance Ongoing Clinical Trials in Atopic Dermatitis and Ulcerative Colitis and Initiate Additional Clinical Programs
Aug 18, 2020 08:30PM Form 3 Inhibrx, Inc. For: Aug 18 Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2020 04:25PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30
Aug 11, 2020 07:00AM Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Aug 11, 2020 07:00AM Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Aug 10, 2020 04:02PM Novavax Reports Second Quarter 2020 Financial and Operational Results
Aug 10, 2020 04:02PM Novavax Reports Second Quarter 2020 Financial and Operational Results
Aug 10, 2020 01:00AM Saniona successfully raises USD 65 million (approximately SEK 567 million) in a directed issue of shares
Aug 6, 2020 09:40AM Aerovate Therapeutics Emerges From RA Capital Incubator With $72.6 Million Funding for Potential Disease-Modifying Pulmonary Arterial Hypertension Therapy
Aug 6, 2020 05:30AM T-knife Completes €66 Million Series A Financing to Develop Next-Generation T-Cell Therapies
Aug 6, 2020 05:30AM T-knife Completes €66 Million Series A Financing to Develop Next-Generation T-Cell Therapies
Aug 5, 2020 04:30PM Form SC 13D iTeos Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 5, 2020 07:00AM GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimm
Aug 3, 2020 08:00AM PMV Pharma Closes $70 Million in Series D Financing
Jul 30, 2020 07:17AM Cerevel Therapeutics and SPAC Arya Sciences Acquisition Corp II (ARYBU) Announce Business Combination
Jul 30, 2020 07:00AM  Cerevel Therapeutics and Arya Sciences Acquisition Corp II Announce Business Combination, Creating a Publicly Listed Leader in Neuroscience Drug Development
Jul 29, 2020 09:36PM Form 4 iTeos Therapeutics, Inc. For: Jul 28 Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 29, 2020 09:00AM Piramal Pharma Solutions Announces Integrated Development Program with Bolt Biotherapeutics for Immune-Stimulating Antibody Conjugates and Sterile Fill-Finish
Jul 24, 2020 04:34PM Form SC 13D Nkarta, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 23, 2020 09:00PM Form 3 Inozyme Pharma, Inc. For: Jul 23 Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 22, 2020 08:00AM Olema Oncology Announces $54 Million Series B Financing
Jul 17, 2020 07:55AM Verona Pharma plc (VRNA) Raises $200 Million in Oversubscribed Private Placement and Subscription
Jul 17, 2020 02:00AM Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription
Jul 17, 2020 02:00AM Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription
Jul 16, 2020 08:52PM Form 3 Pandion Therapeutics, For: Jul 16 Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 13, 2020 02:21PM Vaxart (VXRT) Raises Approximately $90M in Gross Proceeds Through its At-The-Market-Facility (Earlier)
Jul 13, 2020 01:34PM Vaxart Raises Approximately $90M in Gross Proceeds Through its At-The-Market-Facility
Jul 10, 2020 04:34PM Form SC 13G Vaxcyte, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 10, 2020 04:30PM Form SC 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 10, 2020 04:25PM Form SC 13G/A Verastem, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 10, 2020 04:15PM Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Closing of $135.7 Million Initial Public Offering, Including the Full Exercise of the Underwriter’s Option To Purc
Jul 9, 2020 08:58PM Form 3 Nkarta, Inc. For: Jul 09 Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 8, 2020 12:38PM Therapeutics Acquisition Corp. (TXAC) Prices 11.8M Class A Share IPO at $10/Sh
Jul 8, 2020 12:25PM Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
Jul 7, 2020 07:00AM Vor Biopharma Closes $110 Million Series B Financing
Jul 1, 2020 08:30AM Bolt Biotherapeutics Closes $93.5 Million Series C Financing
Jun 26, 2020 12:00AM Artiva Biotherapeutics Launches with $78 Million Series A Financing to Advance NK Cell Therapies to Treat Cancer
Jun 25, 2020 09:12PM Form 3 Akouos, Inc. For: Jun 25 Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 25, 2020 05:02PM Form SC 13D Forma Therapeutics Holdi Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 22, 2020 09:52AM Nkarta Therapeutics Presents Preclinical Findings Supporting Gene Editing of Natural Killer Cells and the Combination of Engineered NK plus T Cells at the American Association for Cancer Research (AAC
Jun 22, 2020 09:52AM Nkarta Therapeutics Presents Preclinical Findings Supporting Gene Editing of Natural Killer Cells and the Combination of Engineered NK plus T Cells at the American Association for Cancer Research (AAC
Jun 18, 2020 09:26PM Form 3 Forma Therapeutics Holdi For: Jun 18 Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 16, 2020 08:00AM C4 Therapeutics Raises $170 Million Financing to Bring Robust Pipeline of Protein Degraders to Clinical Proof-of-Concept and to Advance Proprietary Platform
Jun 15, 2020 10:10AM Novavax (NVAX) Raises $200M from Private Placement with RA Capital
Jun 15, 2020 10:09AM Novavax to Raise $200 Million from Private Placement with RA Capital
Jun 15, 2020 10:09AM Novavax to Raise $200 Million from Private Placement with RA Capital
Jun 10, 2020 04:16PM Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 4, 2020 08:15PM Everest Medicines Completes US$310 Million Series C Financing
May 29, 2020 08:00AM Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
View More Recent Stories View Older Stories